Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Head & Neck 1Breast 1

Conditions

Thyroid Neoplasms 1Renal Insufficiency, Chronic 1Prostatic Neoplasms 1Kidney Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Has results × perflutren × Clear all
NCT04136912 2025-10-06

3-D Super Resolution Ultrasound Microvascular Imaging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
27 enrolled 12 charts
BreastHead & Neck

Breast Neoplasms, Thyroid Neoplasms

NCT02967458 2025-04-30

Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study

Thomas Jefferson University

Phase 2 Completed
55 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT03907657 2024-05-21

CEUS-VHL

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
15 enrolled 7 charts

Renal Insufficiency, Chronic

NCT04021238 2023-11-13

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
25 enrolled 28 charts
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡